Neurodyn

Neurodyn is a company that focuses on identifying, validating, and developing bioactive compounds for neuroprotection and the early treatment of neurological diseases. They achieve this by utilizing a portfolio approach and identifying bioactive compounds within historically-proven natural treatments. Their goal is to validate therapeutic candidates and ultimately develop treatments for Parkinson’s, Alzheimer’s, ALS, and chronic nerve pain. Neurodyn plans to out-license or sell validated therapeutic candidates to pharmaceutical and consumer health players. They also explore faster alternatives to traditional drug development, such as the US FDA Medical Food designation. Neurodyn's unique advantage comes from their strong development capacity, which includes international partners with historical knowledge of natural compounds, in-house medicinal chemistry capability, and proprietary animal models of neurological disease.